Immuneering Corporation (IMRX) Current Ratio
- Current ratio · latest quarter: Value 19.47×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 19.47× | Current assets / current liabilities. $157.99M ÷ $8.12M ≈ 19.47× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 157.99M USD | Assets, Current |
| Current obligations | 8.12M USD | Liabilities, Current |
| Cash and equivalents | 41.32M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current · Debt Securities, Available-for-sale, Current |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 3.38M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $157.99M | $8.12M | $41.32M | (m) | (m) | (m) | $3.38M | (m) | 19.47× |
| 2026-03-31 | $161.41M | $4.97M | $47.32M | (m) | (m) | (m) | $1.45M | (m) | 32.45× |
| 2025-12-31 | $176.25M | $10.07M | $128.65M | (m) | (m) | (m) | $1.54M | (m) | 17.50× |
| 2025-09-30 | $229.10M | $9.55M | $227.56M | (m) | (m) | (m) | $1.60M | (m) | 24.00× |
| 2025-06-30 | $27.73M | $7.49M | $26.36M | (m) | (m) | (m) | $2.40M | (m) | 3.70× |
| 2025-03-31 | $38.21M | $5.11M | $35.87M | $0.00 | (m) | (m) | $1.31M | (m) | 7.48× |
| 2024-12-31 | $39.59M | $7.50M | $36.14M | (m) | (m) | (m) | $1.96M | (m) | 5.28× |
| 2024-09-30 | $55.26M | $6.92M | $45.21M | $5.45M | (m) | (m) | $1.94M | (m) | 7.99× |
| 2024-06-30 | $63.69M | $6.78M | $59.73M | $0.00 | (m) | (m) | $2.62M | (m) | 9.39× |
| 2024-03-31 | $74.45M | $5.18M | $66.29M | $4.99M | (m) | (m) | $2.27M | (m) | 14.38× |
| 2023-12-31 | $89.08M | $7.85M | $59.41M | $26.26M | (m) | (m) | $2.11M | (m) | 11.35× |
| 2023-09-30 | $100.58M | $5.62M | $68.04M | $29.20M | $0.00 | (m) | $1.94M | (m) | 17.89× |
| 2023-06-30 | $111.51M | $5.48M | $104.02M | $4.97M | $0.00 | (m) | $2.69M | (m) | 20.35× |
| 2023-03-31 | $94.23M | $5.53M | $77.43M | $14.11M | $1.05K | (m) | $2.72M | (m) | 17.05× |
| 2022-12-31 | $108.75M | $8.05M | $72.64M | $32.89M | $12.42K | (m) | $3.15M | (m) | 13.50× |
| 2022-09-30 | $120.02M | $7.26M | $76.42M | $40.78M | $70.18K | (m) | $2.34M | (m) | 16.54× |
| 2022-06-30 | $129.17M | $3.80M | $87.94M | $40.16M | $178.43K | (m) | $1.24M | (m) | 33.99× |
| 2022-03-31 | $139.53M | $3.67M | $75.21M | $62.57M | $279.61K | (m) | $1.64M | (m) | 37.98× |
| 2021-12-31 | $152.33M | $5.63M | $74.89M | $74.31M | $246.04K | (m) | $1.39M | (m) | 27.04× |
| 2021-09-30 | $153.31M | $5.27M | $106.93M | $42.55M | $471.38K | (m) | $1.80M | (m) | 29.11× |
| 2021-06-30 | $51.44M | $4.83M | $50.25M | (m) | $495.11K | (m) | $1.43M | (m) | 10.65× |
| 2020-12-31 | $37.73M | $2.26M | $37.09M | (m) | $500.11K | (m) | $1.48M | (m) | 16.73× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |